#endometrial-cancer — Friday, September 04, 2026 (1 items)
| 0 | ℹ |
Cadonilimab plus lenvatinib in advanced endometrial cancer: the multicenter single-arm phase II CLEAR-EC trial.
(nature.com)
|
Nature Communications 2026-09-04 | #clinical trial #immunotherapy #endometrial-cancer #biomarker |